Physician
Michael a Deck MD PA
Michael a Deck MD PA was paid $2K by Medicaid between Aug 2021 and Nov 2024, across 47 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 41% of everything it billed.
33Billing provider infoMICHAEL A DECK MD PA
PLANO, TX 75093
PLANO, TX 75093
33aNPI1053373894assigned 04/05/2006
33bProvider typeCytopathology Physician
28Total paid$2K
24GClaims8,491
24DCodes billed47
24AFirst – last monthAug 2021 – Nov 2024
Compared with peers
Next to other Cytopathology Physician providers in Texas
Rank by total paid#13 of 14
Median peer was paid$43K
This provider vs. median0.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 15 | $723.94 | |
| 2022 | 48 | $1K | |
| 2023 | 8,034 | $664.90 | |
| 2024incomplete | 394 | $37.33 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 41% | 48 | 26 | $1K |
| 88307 | 30% | 15 | 13 | $723.94 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.4% | 138 | 134 | $156.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.0% | 83 | 76 | $98.00 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.9% | 1,720 | 1,165 | $94.96 |
| 80053 | Comprehensive metabolic panel | 2.6% | 1,202 | 885 | $62.15 |
| 83735 | 1.9% | 177 | 81 | $45.04 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.8% | 304 | 136 | $42.66 |
| 82247 | 1.6% | 155 | 51 | $37.98 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.2% | 43 | 41 | $29.48 |
| 84484 | <1% | 247 | 172 | $20.94 | |
| 85027 | <1% | 141 | 75 | $16.29 |
35 more codes
| 84100 | <1% | 57 | $15.92 | |
| 86901 | <1% | 340 | $10.04 | |
| 86900 | <1% | 328 | $10.04 | |
| 86880 | <1% | 55 | $9.06 | |
| 87430 | <1% | 35 | $9.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 38 | $8.16 |
| 81001 | <1% | 516 | $7.31 | |
| 81025 | <1% | 92 | $7.00 | |
| 84703 | <1% | 276 | $6.32 | |
| 83690 | <1% | 222 | $5.79 | |
| 82248 | <1% | 72 | $4.22 | |
| 85018 | <1% | 61 | $1.99 | |
| 85014 | <1% | 67 | $1.99 | |
| 81003 | <1% | 28 | $1.89 | |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 74 | $0.00 |
| 86592 | 0% | 50 | $0.00 | |
| 83605 | 0% | 79 | $0.00 | |
| 86850 | 0% | 97 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 67 | $0.00 |
| 85730 | 0% | 52 | $0.00 | |
| 82962 | 0% | 910 | $0.00 | |
| 86140 | 0% | 25 | $0.00 | |
| 87340 | 0% | 150 | $0.00 | |
| 83880 | 0% | 38 | $0.00 | |
| 84132 | 0% | 15 | $0.00 | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 0% | 106 | $0.00 |
| 85379 | 0% | 14 | $0.00 | |
| 87420 | 0% | 32 | $0.00 | |
| 85610 | 0% | 90 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 53 | $0.00 |
| 84702 | 0% | 41 | $0.00 | |
| 84550 | 0% | 29 | $0.00 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 0% | 75 | $0.00 |
| 80061 | Lipid panel | 0% | 17 | $0.00 |
| 84145 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDECK, MICHAEL (PRESIDENT)